Latest Breaking News On - Pharmaceuticals corporation - Page 20 : comparemela.com

Adamis Pharmaceuticals (ADMP) Announces 1:70 Reverse Stock Split

Adamis Pharmaceuticals (ADMP) Announces 1:70 Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Relationsrobert uhlmanaging directoricr westwickePharmaceuticals corporationCompany special meeting of stockholdersPharmaceuticals corporatoinExchange commissionAdamis pharmaceuticals corporationAdamis pharmaceuticalsNasdaq capital marketSpecial meetingRestated certificatePrivate securities litigation reform actAnnual reportAdamis investor relationsrobert uhlmanaging

Adamis Pharmaceuticals Announces Reverse Stock Split

Adamis Pharmaceuticals Announces Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Relationsrobert uhlmanaging directoricr westwickeCompany special meeting of stockholdersPharmaceuticals corporationExchange commissionPharmaceuticals corporatoinAdamis pharmaceuticalsAdamis pharmaceuticals corporationWall streetNasdaq capital marketSpecial meetingRestated certificatePrivate securities litigation reform actAnnual reportAdamis investor relationsrobert uhlmanaging

Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Announces Reverse Stock Split

SAN DIEGO, May 19, 2023 (GLOBE NEWSWIRE) Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, announced today that it will effect a 1-for-70 reverse stock

Robert uhlGewinn nurPharmaceuticals corporatoinAdamis pharmaceuticals corporationExchange commissionPharmaceuticals corporationAdamis pharmaceuticalsCompany special meeting of stockholdersNasdaq capital marketSpecial meetingRestated certificatePrivate securities litigation reform actAnnual report

Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Relationsrobert uhlmanaging directoricr westwickeExchange commissionAdamis pharmaceuticalsAdamis pharmaceuticals corporationPharmaceuticals corporationCompany common stockPharmaceuticals corporation the agreementToll internationalMarket valueListed securitiesNasdaq capitalCall informationToll freeInternational dial inPrivate securities litigation reform actCommon stock

Novartis presents new five-year data on disability outcomes and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosis

The ALITHIOS open-label extension study showed continuous treatment with Kesimpta® (ofatumumab) for up to five years in relapsing multiple sclerosis (RMS).

United statesCity ofUnited kingdomWallstroeme ofatumumabSloan simpsonJeffreya cohenPrnewswire novartisJulie masowMarlena abdinoorAmerican academy of neurologyNovartis pharmaceuticals corporationExchange commissionNational ms societyNovartis pharmaceuticals corpNeurological institute at cleveland clinicNj novartis pharmaceuticals corporation